Xenetic Biosciences (XBIO) Current Deferred Revenue (2016 - 2018)
Xenetic Biosciences' (XBIO) quarterly Current Deferred Revenue came in at $6703.0 in Q3 2018, down 68.19% YoY from $21071.0 in Q3 2017, and down 41.17% on a QoQ basis from $11394.0 in Q2 2018.
Xenetic Biosciences (XBIO) Current Deferred Revenue (2016 - 2018) Analysis & Trends
Xenetic Biosciences (XBIO) has 3 years of Current Deferred Revenue data on file, last reported at $6703.0 in Q3 2018.
- Quarterly Current Deferred Revenue fell 68.19% year-over-year to $6703.0 in Q3 2018, while the trailing twelve-month figure through Sep 2018 was $6703.0 (down 68.19% YoY) and the FY2017 annual result came in at $21234.0, up 5.09% from the prior year.
- Current Deferred Revenue slipped to $6703.0 in Q3 2018, from $11394.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $67495.0 in Q2 2017 to a low of $6703.0 in Q3 2018.
- A 3-year average of $23496.1 and a median of $20205.0 in 2016 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2017 — Current Deferred Revenue climbed 5.09% — and 2018, when it sank 83.12%.
- Tracing XBIO's Current Deferred Revenue over 3 years: stood at $20205.0 in 2016, then grew by 5.09% to $21234.0 in 2017, then tumbled by 68.43% to $6703.0 in 2018.
- The last three Current Deferred Revenue figures came in at $6703.0 (Q3 2018), $11394.0 (Q2 2018), and $16371.0 (Q1 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Xenetic Biosciences | 7.59 Mn | 1.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 6,703.00 |
| Jun 30, 2018 | 11,394.00 |
| Mar 31, 2018 | 16,371.00 |
| Dec 31, 2017 | 21,234.00 |
| Sep 30, 2017 | 21,071.00 |
| Jun 30, 2017 | 67,495.00 |
| Dec 31, 2016 | 20,205.00 |